Clinical TrialsSearch results
Number of results: 614
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- Cardioprotection of SGLT2 inhibitors in elderly diabetes: single-arm study
- Type2 Diabetes
- Matoba Satoaki
- 2019-08-15
Completed
- An intervention study to prevent sarcopenia in hospitalized patients
- Type2 diabetes
- Ikeda Kaori
- 2020-02-18
Completed
- Efficacy of dual therapy of TOfogliflozin and dietary instruction of sodium-restriction in type 2 diabetes Patients with nocturia; multicenter, open-label, randomized-controlled, Superiority Trial for Availability to Reduce nocturnal urination frequency
- type 2 diabetes mellitus, nocturia
- Hamaguchi Masahide
- 2022-03-30
Recruiting
- Sodium zirconium cyclosilicate non-Inferiority on hyperkalemia (Level of serum potassium) VErsus potassium Restricted diet in Subjects with type 2 diabetes mellitus; multicenter, open-label, randomized controlled, Two-Arm Research
- type 2 diabetes mellitus, hyperkalemia
- Hamaguchi Masahide
- 2023-07-11
Other
- Efficacy of Bifidobacteria intake on gastrointestinal symptoms in Symptomatic Type 2 diabetes mellitus patients in Abdominis; open-label, Randomized-controlled trial
- type 2 diabetes mellitus
- Fukui Michiaki
- 2022-12-06
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to an Alpha-Glucosidase Inhibitor
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Completed
- Glucose management impact of "asken medical system" in patients with type 2 diabetes.
- Type 2 diabetes
- Kawashima Sachiko
- 2022-09-27
Not yet recruiting
- Relationship between compliance of Self-Monitoring of Blood Glucose (SMBG) and control of blood glucose
- Type 2 diabetes
- Dapartment of Diabetes and Clinical Nutrition, Graduate School of Medicine, Kyoto Universiy
- 2009-01-01
Other
- Primary prevention of cerebrovascular and cardiovascular events with an oral antidiabetic agent in patients with type 2 diabetes at high risk for cerebral infarction
- Type 2 Diabetes
- PROFIT-J Study Steering Committee
- 2007-10-09